Shimadzu (7701) AI Stock Analysis

• Market Cap: ¥1.27T
• Dividend Yield: 1.46%
• Average Volume (3M): 736.29K
• Price to Earnings (P/E): 22.3
• Beta (1Y): 0.73
• Revenue Growth: 3.92%
• EPS Growth: 9.99%
• Country: JP
• Employees: 14,519
• Sector: Technology
• Sector Strength: 88
• Industry: Hardware, Equipment & Parts
• EPS (TTM): 54.37
• Shares Outstanding: 296,070,250
• 10 Day Avg. Volume: 746,230
• 30 Day Avg. Volume: 736,290
• PEG Ratio: -3.94
• Price to Book (P/B): 2.19
• Price to Sales (P/S): 2.03
• P/FCF Ratio: 29.62
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥5,000.00
• Price Target Upside: 17.32% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 75 Outperform
• Price Target: ¥4,573.00 ▲(7.30% Upside)

Shimadzu's strong financial performance is the most significant factor, supported by healthy revenue and profit growth, and a solid balance sheet. Technical analysis indicates positive momentum, though caution is advised due to overbought signals. Valuation metrics suggest the stock may be slightly overvalued, which tempers the overall score.

Positive Factors

Revenue Growth

Consistent revenue growth indicates strong market demand for Shimadzu's products, supporting long-term business expansion and stability.

Balance Sheet Health

A strong balance sheet with low financial leverage enhances Shimadzu's financial stability and ability to invest in growth opportunities.

Cash Flow Generation

Robust cash flow generation supports Shimadzu's ability to fund operations, invest in R&D, and return value to shareholders sustainably.

Negative Factors

EPS Growth Decline

A decline in EPS growth could indicate challenges in profitability or increased costs, potentially impacting long-term earnings potential.

Profit Margin Pressure

While margins are healthy, negative EPS growth suggests pressure on profitability, which could affect future financial performance.

Market Valuation Concerns

A high P/E ratio may indicate overvaluation, potentially limiting stock price appreciation and increasing risk if growth expectations are not met.

Shimadzu Business Overview & Revenue Model

Company Description

Shimadzu Corporation manufactures and sells analytical and measuring instruments, medical systems, industrial machinery, and aircraft equipment worldwide. Its analytical instruments include gas and liquid chromatography, gas and liquid chromatograph-mass spectrometry, data management and software, molecular spectroscopy, elemental analysis, surface analysis, life science lab instrument, total organic carbon analysis, continuous monitoring analysis, thermal analysis, particle size analysis, materials testing and inspection, non-destructive testing, and balance products. It provides medical systems comprising angiography, fluoroscopy, mobile C-arm, radiography, mobile X-ray systems, and fluorescence imaging products; consist of diffraction gratings, aspherical mirrors, laser mirrors and windows for high power lasers, polka-dot beam splitters, and precision refractometers. The company also offers industrial machinery, including turbo molecular pumps, helium leak detectors, sputtering system, multi deposition system, vacuum heat-treatment furnaces, liquid delivery equipment gear pumps, mechatronic systems glass fiber winders, liquid crystal injection system, and dynamic balancing machines. Further, it provides hydraulic equipment, such as hydraulic gear pumps, power packages, and multi control valves; and aircraft equipment, including electro-mechanical actuators, flight control systems, landing gear systems, and electro-mechanical actuators. Shimadzu Corporation was founded in 1875 and is headquartered in Kyoto, Japan.

How the Company Makes Money

Shimadzu generates revenue through multiple streams, primarily from the sale of high-precision instruments and equipment used in laboratories and medical settings. Its key revenue streams include the sale of analytical instruments, medical imaging solutions, and environmental and industrial testing systems. The company also earns income from maintenance services, consumables, and software solutions associated with its equipment. Significant partnerships with educational institutions, research organizations, and healthcare providers enhance its market reach and support its sales efforts. Additionally, Shimadzu invests in R&D to innovate and develop new technologies, which helps maintain its competitive edge and drive future growth.

Shimadzu Financial Statement Overview

Summary

Shimadzu demonstrates strong financial health with consistent revenue growth, robust profit margins, and effective cost management. The balance sheet is solid with low financial leverage, and cash flow generation is healthy, supporting sustainable growth.

Income Statement

Shimadzu has shown consistent revenue growth with a notable increase in total revenue over recent years. The gross profit margin is strong, indicating efficient production and cost management. The net profit margin is healthy, reflecting solid profitability. EBIT and EBITDA margins are robust, suggesting effective operational management.

Balance Sheet

The company maintains a strong equity position relative to its total assets, leading to a favorable equity ratio. The debt-to-equity ratio is low, indicating prudent financial leverage. Return on equity is solid, demonstrating effective use of shareholder funds to generate profits.

Cash Flow

Shimadzu's cash flow from operations is strong and covers its capital expenditures, leading to positive free cash flow. The free cash flow growth rate is favorable, showing increasing cash generation. The operating cash flow to net income ratio is solid, indicating good cash conversion efficiency.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	540.48B	539.05B	511.89B	482.24B	428.18B	393.50B
Gross Profit	237.62B	234.44B	220.84B	200.96B	178.62B	156.19B
EBITDA	90.08B	91.90B	95.81B	89.02B	82.55B	65.74B
Net Income	51.71B	53.77B	57.04B	52.05B	47.29B	36.10B
Balance Sheet
Total Assets	647.30B	672.18B	673.96B	618.87B	560.53B	497.46B
Cash, Cash Equivalents and Short-Term Investments	137.95B	143.41B	165.28B	159.27B	157.97B	112.76B
Total Debt	11.07B	15.28B	11.91B	11.27B	11.59B	10.26B
Total Liabilities	153.75B	174.10B	181.63B	195.37B	179.37B	161.96B
Stockholders Equity	493.54B	498.06B	492.33B	423.50B	381.16B	335.50B
Cash Flow
Free Cash Flow	0.00	36.90B	14.63B	31.46B	53.24B	50.49B
Operating Cash Flow	0.00	52.00B	30.13B	48.30B	63.37B	63.80B
Investing Cash Flow	0.00	-23.17B	-16.00B	-34.51B	-6.04B	-13.86B
Financing Cash Flow	0.00	-48.41B	-21.10B	-19.42B	-15.66B	-13.03B

Shimadzu Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 4262.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7701, the sentiment is Positive. The current price of 4262 is above the 20-day moving average (MA) of 4260.50, below the 50-day MA of 4292.98, and above the 200-day MA of 3763.60, indicating a bullish trend. The MACD of -11.70 indicates Negative momentum. The RSI at 53.79 is Neutral, neither overbought nor oversold. The STOCH value of 70.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7701.

Shimadzu Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6856	77 Outperform	¥690.06B	18.30	11.99%	0.65%	8.50%	14.06%
7701	75 Outperform	¥1.27T	22.26	10.84%	1.46%	3.92%	9.99%
6965	74 Outperform	¥517.07B	35.37	4.19%	2.25%	3.97%	-41.76%
6951	65 Neutral	¥262.65B	14.95	―	2.04%	-0.69%	-29.88%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
6645	60 Neutral	¥789.88B	27.59	3.60%	2.62%	3.51%	―

Shimadzu Corporate Events

Shimadzu to Acquire Tescan, Expanding Global Electron Microscopy and Analytical Solutions Business

Shimadzu has agreed to acquire Tescan Group, a European pioneer in electron microscopy, by purchasing all shares of Glass HoldCo s.r.o., the special purpose company that indirectly owns Tescan, thereby making Tescan a wholly owned subsidiary. The deal deepens a partnership that began with a 2024 business alliance and joint-branded SEM products and is intended to integrate Tescan’s strengths in surface observation and analysis—through SEM, FIB-SEM, TEM and Micro-CT systems—with Shimadzu’s capabilities in composition and physical property analysis, expanding its analytical measurement lineup and global reach. By leveraging Shimadzu’s customer network and support infrastructure alongside Tescan’s broad international customer base, the company aims to accelerate its transformation into a comprehensive solutions provider, boost sales of advanced electron microscopy systems, and drive joint development of new products and applications, supporting medium- to long-term growth and competitiveness in the analytical instrumentation market.

The most recent analyst rating on (JP:7701) stock is a Buy with a Yen4573.00 price target. To see the full list of analyst forecasts on Shimadzu stock, see the JP:7701 Stock Forecast page.

Shimadzu Corporation Announces Increased Interim Dividend

Shimadzu Corporation announced an interim dividend of 27 yen per share, reflecting a 1 yen increase from the previous forecast, with a total dividend payout of 7,803 million yen. This decision aligns with Shimadzu’s policy of maintaining stable dividends while considering earnings performance and cash flows, indicating a positive outlook on the company’s financial health and commitment to shareholder returns.

The most recent analyst rating on (JP:7701) stock is a Buy with a Yen4573.00 price target. To see the full list of analyst forecasts on Shimadzu stock, see the JP:7701 Stock Forecast page.

Shimadzu Corporation Reports Increased Profits and Revised Dividend Forecast

Shimadzu Corporation reported its consolidated financial results for the six months ending September 30, 2025, showing a 2% increase in net sales and a 10.9% rise in profit attributable to owners of the parent compared to the previous year. The company also announced a revision to its cash dividend forecast, reflecting a slight increase, and adjusted its earnings forecast for the fiscal year ending March 31, 2026, indicating stable growth and a positive outlook for stakeholders.

The most recent analyst rating on (JP:7701) stock is a Buy with a Yen4573.00 price target. To see the full list of analyst forecasts on Shimadzu stock, see the JP:7701 Stock Forecast page.